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Abstract. Intracerebral injeotion of 1 [j.1 volumes of solutions containing nor­
adrenaline, clonidine, oxymetazoline and phentolamine were performed in the 
antero-lateral hypothalamus of the Wistar rat at the level of the pars infraoom- 
missuralis of the Stria terminalis.
Intrahypothalamic clonidine in a dose as low as 1 [i.g strongly increased food 
intake in satiated rats.
Clonidine (4 [Ag) was more potent than noradrenaline (12 jzg) but as potent as 
oxymetazoline (1.5 jxg).
The clonidine induced eating response was completely blocked by the a-sym- 
patholytic drug phentolamine.
The results emphasize the role of clonidine as an activator o f noradrenaline 
receptors in the central nervous system.
Key words: Noradrenaline — Clonidine — Adrenergic Imidazolines — Central 
Noradrenaline Receptors — Intracerebral Injections — Hypothalamic Eating 
System.
Introduction
There is considerable evidence that the adrenergic imidazolines 
such as naphazoline, oxymetazoline and xylometazoline are direct 
a-receptor activators (Mujic and van Rossum, 1965). The recent 
antihypertensive agent, clonidine, an analogue of the adrenergic 
stimulant imidazolines, likewise shows peripheral cc - sympathomimetic 
effects (Boissier et al., 1968; Kobinger, 1967).
Several reports provide evidence for a central mechanism of action 
of clonidine (Shaw et al., 1971; Schmidt et al., 1969; Sherman et al., 
1968) and «-adrenergic blocking agents inhibit these actions of cloni­
dine (Schmidt et al., 1970 and 1971). However, clonidine has not yet 
been administered directly into the central nervous system.
Adrenergic stimulants increase eating in satiated animals when 
introduced directly in the lateral hypothalamus (Grossman, 1962). 
By using selective ot- and adrenergic stimulants as well as selective 
antagonists it was shown that noradrenergic receptor activation is
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the cause of intrahypothalamic noradrenaline facilitated eating 
(Slangen and Miller, 1969).
Sinee chemical stimulation of eating in the lateral hypothalamus 
is a clean model for central a-adrenergic drug-receptor interaction, we 
used this model to study the central effects of clonidine and oxy- 
metazoline.
Methods and Materials
Stereotaxic Operations
Cannulae with an outer diameter of 0.8 mm were implanted under 
stereotaxic conditions in the antero-lateral hypothalamus of male 
rats (250—300 g) under pentothal (50 mg/kg) anaesthesia. The tip of 
the cannula was placed in a position anterior 7.6, lateral 1.4 and deep 
— 2.4, according to the atlas of König and Klippel (1963). The 
cannulae were fixed to the skull with dental cement, and a circular 
wall of cement was applied to the extending part of the cannula. The 
ring so formed was filled with latex (Rhodorsil®) in order to fixate 
the plug of the cannula, and prevent the rat from scratching the 
cannula after recovery from surgery.
Intrahypothalamic Injection
The chemicals were dissolved in saline. The freshly prepared solu- 
tions were injected with a Hamilton syringe with an adjustable screw 
on the needle such that the solution could be deposited some distance 
(e.g. 0.5 mm) beyond the tip of the cannula. By this procedure local 
destruction of brain tissue could be minimized. 8 consecutive in- 
jections were made in the same rat over a period of 3 weeks (see 
Table 1). The site of injection was controlled at the end of the experi­
ment (Fig. 1). In six out of seven rats, the position of the cannula was 
correct.
The actual site of injection was established histologically. The 
average position of the injection site corresponded to anterior 6.25, 
lateral 1.2 and depth — 2.0. This implied that the chemicals were 
deposited around the pars infracommissuralis of the Stria terminalis.
Chemicals
(—)Noradrenaline (40 nmol =  12.7 (Ag of hydrogen tartrate) was 
used as a reference drug. Clonidine was used initially in a dose of 
200 nmol ( =  53.3 \ig of HC1 salt) but later reduced to 50 nmol 
( =  13.3 j j i g ) ; 15 nmol ( =  4 f j - g )  and 3.84 nmol ( =  1 [ A g ) .  Oxymetazoline 
was used in a dose of 5 nmol ( =  1.5 ( A g ) .  The alpha-sympatholytic
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Fig.1. a Frontal section of the rat brain according to the atlas of König and 
Klippel in which the sites of application of the chemicals have been indicated. The 
numbers refer to the different rats. b Sagital section of the rat brain in which 
the sites of injeetion have been indicated. In all rats except number 1, the position 
of the cannula appeared to be correct. For results of the various experiments see
Table 1
drug phentolamine was used in a dose of 53 nmol (=  15 [Ag) one half 
hour prior to 15 nmol clonidine. All doses or combinations were 
applied 6 times except for the initial experiments.
12 Psychopharmacologia (Berl.), Vol. 25
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Eating Response
The experiments were carried out in normal rat cages, by measur- 
ing the food intake in the first hour after intrahypothalamic injection. 
The rats were habituated to the cage by placing them in the test 
cage 5 times during one hour periods prior to the experiments, the 
last time after 24 h of food deprivation. During the experiments the 
rats had free aecess to food.
M esults
Fr om the 24 h food deprivation test it appeared that the rats were 
accustomed to the test cage since they consumed about 3 g in half 
an hour (Table 1).
The effeets of the various intrahypothalamic injections in the 
individual rats are given in Table 1, together with the sequence of 
injections in each rat. Injection of the reference substance levo- < 
noradrenaline was effective in six of seven rats, causing an average 
food intake of 3.8 g, whereas the food consumption following a saline 
injection amounted to about 0.8 g (Table 1). In one rat noradrenaline 
only induced a food consumption of 1.5 g. Injections deeper in the 
hypothalamus were no more effective so that this rat was excluded
fo o d  in t a k e  ( g / h )
N A  S a lin e  C lon . C lon . C lon. C lon. O M Z  S a lin e  C lon . phento lam ine 
40  200  50  15 3.8 5 15 53.4nmol
+ C lo n .
15 nmol
Fig.2. Meanfood intake in6satiated rats with cannulaeinthe correct position follow­
ing intrahypothalamic injection of saline, noradrenaline, oxymetazoline and cloni- 
dine. The alphasympathomimetic drugs elicit a strong increase in food intake, 
while the alphasyinpatholytie phentolamine completely abolishea the effect of an 
adequate dose of clonidine
from further experiments. From the histological control it appeared 
that in this rat the site of injection was too far posterior (Fig. 1).
Clonidine induced a strong eating response in all doses from 
200—15 nmol (Fig. 2), and even 4 nmol was fully effective. It may 
be concluded that intrahypothalamically injected clonidine is more 
potent than noradrenaline, since 5 nmol of the latter given under 
similar conditions is ineffective (Slangen, 1970).
The adrenergic imidazoline, oxymetazoline also strongly increased 
eating in a dose of 5 nmol, and it is therefore likewise more potent 
than noradrenaline.
Intrahypothalamically stimulated eating by clonidine is completely 
blocked by the «-adrenergic blocking agent phentolamine, when in­
jected at the same site in the hypothalamus, half an hour prior to 
clonidine. It may therefore be concluded that clonidine acts by 
activation of noradrenaline receptors in the hypothalamus.
The sites of injection cluster around the pars infracommisuralis 
of the Stria terminalis. See Fig.1.
Biscussion
During the onehour period following intrahypothalamic injection, 
clonidine induces a greater food consumption than noradrenaline. 
This may h o wever be due to a greater stability of clonidine over 
noradrenaline, rather than to a greater intrinsic potency. Clonidine 
differs from oxymetazoline only with respect to its high lipophylicity. 
This explains why clonidine easily passes the bloodbrain-barrier where- 
as oxymetazoline does not reach the brain in adequate amounts 
following systemic injection.
Clonidine also exerts local anaesthetic properties equal to procaine 
(Hoefke and Kobinger, 1966). Clonidine induced eating cannot, how- 
ever, be caused by a local anaesthetic effect since a selective a-sym- 
patholytic drug phentolamine abolishes the eating response of clo­
nidine.
The imidazolines are pure alpha-receptor activators as they lack 
beta-sympathomimetic activity (Mujic and van Rossum, 1965).
From studies on specific dopamine- and 5-hydroxytryptamine- 
sensitive neurons of the snail brain, it is found that clonidine does 
not activate dopamine- or 5-hydroxytryptamine-reeeptors (Woodruff, 
unpublished data).
It may be concluded that clonidine acts on the hypothalamic 
eating system by activation of noradrenaline receptors which are 
analogous to the alpha-adrenergic receptors of the peripheral auto­
nomie nervous system.
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Cardiovascular studies in our laboratory with intracerebral in- 
jection  o f  clonidine provide evidence for a depressor effect o f  clonidine 
when in jected  in distinct areas o f  the hypothalam us (Struyker B oudier 
et al., 1972). These studies further substantiate the role o f  clonidine 
as an activator o f  brain noradrenaline receptors.
Follow ing oral adm inistration in patients with hypertension 
clonidine m ainly exerts hypotensive effects. I t  m ay h o we ver be 
anticipated that in higher doses various behavioral effects m ight 
occur since noradrenaline plays an im portant role in various parts o f  
the brain.
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